Disc Medicine earnings were -$243.1M for the trailing 12 months ending Sep 30, 2026, with N/A growth year over year. The latest IRON earnings report on Sep 30, 2026 announced Q3 2026 earnings of -$59.5M, up 0% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, IRON reported annual earnings of -$212.2M, with 94% growth.
On IRON's earnings call on Nov 5, 2026, Disc Medicine (NASDAQ: IRON) reported Q3 2026 earnings per share (EPS) of -$1.53, up 13.56% year over year. Total IRON earnings for the quarter were -$59.54 million. In the same quarter last year, Disc Medicine's earnings per share (EPS) was -$1.77.
As of the last Disc Medicine earnings report, Disc Medicine is currently losing money. Disc Medicine's net profit (also called net income) for the twelve months ending Sep 30, 2026 was -$243.10 million, a 34.23% increase year over year.
What was IRON's earnings growth in the past year?
As of Disc Medicine's earnings date in Nov 5, 2026, Disc Medicine's earnings has grown year over year. IRON earnings in the past year totalled -$243.10 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.